Literature DB >> 9087173

Polarized expression of HD1: relationship with the cytoskeleton in cultured human colonic carcinoma cells.

L Fontao1, S Dirrig, K Owaribe, M Kedinger, J F Launay.   

Abstract

Hemidesmosomes (HDs) mediate adhesion of epithelial cells to the extracellular matrix and have morphological associations with intermediate-size filaments (IFs). Hemidesmosomal molecular components including HD1, the two bullous pemphigoid antigens, and the integrin alpha 6 beta 4 have been identified in HDs of stratified and complex epithelium. In this study, we report that HT29-Fu cells, a human colonic tumor cell line, express two hemidesmosomal components (HD1, alpha 6 beta 4) associated in an adhesion structure termed type II HDs. Immunofluorescence studies showed a colocalization of HD1 and alpha 6 beta 4 in basal patches between actin stress fibers. Using cytochalasin B or vinblastine, two drugs which disrupt the cytoskeleton, we demonstrate that the redistribution of HD1 was probably induced by the reorganization of the basal cytokeratin network. We also show that in vitro HD1 binds to polymerized cytokeratin intermediate filaments; this suggests that HD1 in intestinal epithelial cells functions as a linker protein connecting cytokeratin filaments to the basal plasma membrane, probably through the beta 4 subunit of the integrin alpha 6 beta 4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087173     DOI: 10.1006/excr.1996.3465

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

1.  Intestinal restitution: progression of actin cytoskeleton rearrangements and integrin function in a model of epithelial wound healing.

Authors:  M M Lotz; I Rabinovitz; A M Mercurio
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Dynamics of the alpha6beta4 integrin in keratinocytes.

Authors:  Cecile A W Geuijen; Arnoud Sonnenberg
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  The association of bullous pemphigoid and ulcerative colitis.

Authors:  Lisbeth Selby; Fernando De Castro; Willem J S De Villiers
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 4.  Intermediate filaments: a role in epithelial polarity.

Authors:  Andrea S Oriolo; Flavia A Wald; Victoria P Ramsauer; Pedro J I Salas
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

Review 5.  Laminin-332-integrin interaction: a target for cancer therapy?

Authors:  Daisuke Tsuruta; Hiromi Kobayashi; Hisayoshi Imanishi; Koji Sugawara; Masamitsu Ishii; Jonathan C R Jones
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 6.  Cellular and molecular partners involved in gut morphogenesis and differentiation.

Authors:  M Kedinger; O Lefebvre; I Duluc; J N Freund; P Simon-Assmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

7.  Protein kinase C-alpha phosphorylation of specific serines in the connecting segment of the beta 4 integrin regulates the dynamics of type II hemidesmosomes.

Authors:  Isaac Rabinovitz; Lobsang Tsomo; Arthur M Mercurio
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures.

Authors:  I Rabinovitz; A M Mercurio
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

9.  Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation.

Authors:  O Lorentz; I Duluc; A D Arcangelis; P Simon-Assmann; M Kedinger; J N Freund
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

10.  Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites.

Authors:  G A Rezniczek; J M de Pereda; S Reipert; G Wiche
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.